Expression of Interleukin-1 and temporomandibular disorder: Contemporary review of the literature

Cranio. 2018 Jul;36(4):268-272. doi: 10.1080/08869634.2017.1342890. Epub 2017 Jun 19.

Abstract

Objective: Temporomandibular disorders (TMD) are a group of conditions affecting the temporomandibular joint (TMJ), leading to jaw dysfunction, joint and muscle pain, and a decrease in quality of life. A communication network of pro- and anti-inflammatory mediators called cytokines maintains the homeostasis of the TMJ. This review will focus on the Interleukin (IL) family of cytokines, which have been quantified in TMJ synovial fluids in a variety of studies. IL-1α and IL-1β have pro-inflammatory effects, while the endogenous receptor antagonist (IL-1RA) inhibits the pro-inflammatory effects of IL-1.

Methods: A literature search (2006-2016) to identify eligible studies was completed using the PubMed database. Studies identified used saline irrigation to quantify cytokine profiles in synovial fluid of healthy and/or dysfunctional joints.

Results: The initial search yielded 111 articles, 5 of which met the inclusion criteria after inter-reviewer discussion.

Conclusions: Articles that compared IL-1 concentrations in TMD vs. control groups found significant differences.

Keywords: Interleukin-1; Temporomandibular joint; temporomandibular joint disorder.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Arthritis, Rheumatoid / metabolism
  • Interleukin-1alpha / metabolism*
  • Osteoarthritis / metabolism
  • Synovial Fluid / metabolism
  • Temporomandibular Joint / metabolism*
  • Temporomandibular Joint Disorders / metabolism*

Substances

  • IL1A protein, human
  • Interleukin-1alpha